Skip to main content

Animations

MJFF Publications

3641 - 3650 of 8571 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2020
  • 2015
  • 2024
  • 2023
  • 2007
  • 2018
  • 2013
  • 2017
  • Summary Details
    OPEN
    Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1813365115
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-191901
    Citation Count: 48
  • Summary Details
    OPEN
    Title: A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.0c00577
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Deep Brain Stimulation in a Case of Mitochondrial Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12241
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01120-4
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Comparison of two protocols for the generation of iPSC-derived human astrocytes
    Journal Name: Biological Procedures Online
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12575-023-00218-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 46
  • Summary Details
    RESTRICTED
    Title: Disease-modifying therapies for Parkinson's disease
    Journal Name: The Biomedical & Life Sciences Collection
    Publisher: Henry Stewart Talks
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.69645/krxj9755
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001
    Best OA location URL:
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.